Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines

MLA

Petra Visser, et al. “Mechanisms for High Methoxymorpholino Doxorubicin Cytotoxicity in Doxorubicin-Resistant Tumor Cell Lines.” International Journal of Cancer, vol. 73, Nov. 1997, pp. 362–66. EBSCOhost, https://doi.org/10.1002/(sici)1097-0215(19971104)73:3<362::aid-ijc10>3.0.co;2-f.

APA

Petra Visser, Harry J.M. Groen, Marleen Bakker, Egbert F. Smit, Anneke Groenhuijzen, Elisabeth G.E. de Vries, Michael Müller, Hetty Timmer-Bosscha, & Johan Renes. (1997). Mechanisms for high methoxymorpholino doxorubicin cytotoxicity in doxorubicin-resistant tumor cell lines. International Journal of Cancer, 73, 362–366. https://doi.org/10.1002/(sici)1097-0215(19971104)73:3<362::aid-ijc10>3.0.co;2-f

Chicago

Petra Visser, Harry J.M. Groen, Marleen Bakker, Egbert F. Smit, Anneke Groenhuijzen, Elisabeth G.E. de Vries, Michael Müller, Hetty Timmer-Bosscha, and Johan Renes. 1997. “Mechanisms for High Methoxymorpholino Doxorubicin Cytotoxicity in Doxorubicin-Resistant Tumor Cell Lines.” International Journal of Cancer 73 (November): 362–66. doi:10.1002/(sici)1097-0215(19971104)73:3<362::aid-ijc10>3.0.co;2-f.